Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.


US, Iran inch closer to deal, timing remains unclear
India Air Force plane crash kills all five onboard
Ukrainian strike kills one, wounds 3 in southern Russia
Trump says US military strike killed leader of Venezuela's Tren de Aragua gang
Qatar rejects media report on energy production decisions
Trump says Iran war deal close as Strait of Hormuz tensions linger
Victims' families mark Air India crash anniversary with prayers and tributes
Ebola outbreak spreads to crowded displacement camp in Congo
